<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35248553</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>12</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>12</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1879-0712</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>922</Volume>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>05</Day>
            </PubDate>
          </JournalIssue>
          <Title>European journal of pharmacology</Title>
          <ISOAbbreviation>Eur J Pharmacol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Coumarins derivatives and inflammation: Review of their effects on the inflammatory signaling pathways.</ArticleTitle>
        <Pagination>
          <StartPage>174867</StartPage>
          <MedlinePgn>174867</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejphar.2022.174867</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0014-2999(22)00128-5</ELocationID>
        <Abstract>
          <AbstractText>Natural and synthetic coumarins have been extensively described in the literature as effective drugs with several pharmacological activities. Many valuable publications have shown the anti-inflammatory potential of these compounds suggesting that coumarins could be an interesting scaffold for developing new therapeutic anti-inflammatory agents. However, despite the continuous efforts of research in this field, no major breakthrough was yet achieved and only a few coumarin-like drugs are commercially available. In the present article, we reviewed the most relevant studies conducted in the last two decades (2000-2021) and presenting evidence for the anti-inflammatory mechanisms of coumarins. The review provides a comprehensive survey of scientific research revealing through multiple in vitro and in vivo models the effect of natural and synthetic coumarins on components of the Toll-like receptors (TLR), Janus Kinase/Signal Transducer and Activator of Transcription (JAK/STAT), Inflammasomes, mitogen-activated protein kinase (MAPK), nuclear factor- κ-light-chain-enhancer of activated B cells (NF- κB) and transforming growth factor-β/small mothers against decapentaplegic (TGF-β/SMAD) pathways.</AbstractText>
          <CopyrightInformation>Copyright © 2022 Elsevier B.V. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Rostom</LastName>
            <ForeName>Batoul</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratoire de Génomique, Bioinformatique et Chimie Moléculaire (EA 7528), Conservatoire National des Arts et Métiers (Cnam), 2 rue Conté, 75003, HESAM Université, Paris, France; Laboratoire de valorisation des ressources naturelles et des produits de santé, Faculté de Pharmacie, Université Libanaise, Campus Universitaire Rafik Hariri, Hadat, Liban.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Karaky</LastName>
            <ForeName>Racha</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratoire de valorisation des ressources naturelles et des produits de santé, Faculté de Pharmacie, Université Libanaise, Campus Universitaire Rafik Hariri, Hadat, Liban. Electronic address: racha.karaky@ul.edu.lb.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kassab</LastName>
            <ForeName>Issam</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratoire de valorisation des ressources naturelles et des produits de santé, Faculté de Pharmacie, Université Libanaise, Campus Universitaire Rafik Hariri, Hadat, Liban.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sylla-Iyarreta Veitía</LastName>
            <ForeName>Maité</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratoire de Génomique, Bioinformatique et Chimie Moléculaire (EA 7528), Conservatoire National des Arts et Métiers (Cnam), 2 rue Conté, 75003, HESAM Université, Paris, France. Electronic address: maite.sylla@lecnam.net.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>03</Month>
          <Day>03</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>Eur J Pharmacol</MedlineTA>
        <NlmUniqueID>1254354</NlmUniqueID>
        <ISSNLinking>0014-2999</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000893">Anti-Inflammatory Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D003374">Coumarins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000893" MajorTopicYN="N">Anti-Inflammatory Agents</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003374" MajorTopicYN="N">Coumarins</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016328" MajorTopicYN="Y">NF-kappa B</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="Y">Signal Transduction</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Coumarins</Keyword>
        <Keyword MajorTopicYN="N">Inflammasomes</Keyword>
        <Keyword MajorTopicYN="N">Inflammatory signaling pathways</Keyword>
        <Keyword MajorTopicYN="N">JAK/STAT pathway</Keyword>
        <Keyword MajorTopicYN="N">MAPK pathway</Keyword>
        <Keyword MajorTopicYN="N">NF-κB pathway</Keyword>
        <Keyword MajorTopicYN="N">TGF-β/SMAD pathway</Keyword>
        <Keyword MajorTopicYN="N">Toll-like receptors</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>6</Day>
          <Hour>20</Hour>
          <Minute>29</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35248553</ArticleId>
        <ArticleId IdType="doi">10.1016/j.ejphar.2022.174867</ArticleId>
        <ArticleId IdType="pii">S0014-2999(22)00128-5</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35248553</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>12</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>12</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1879-0712</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>922</Volume>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>05</Day>
            </PubDate>
          </JournalIssue>
          <Title>European journal of pharmacology</Title>
          <ISOAbbreviation>Eur J Pharmacol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Coumarins derivatives and inflammation: Review of their effects on the inflammatory signaling pathways.</ArticleTitle>
        <Pagination>
          <StartPage>174867</StartPage>
          <MedlinePgn>174867</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejphar.2022.174867</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0014-2999(22)00128-5</ELocationID>
        <Abstract>
          <AbstractText>Natural and synthetic coumarins have been extensively described in the literature as effective drugs with several pharmacological activities. Many valuable publications have shown the anti-inflammatory potential of these compounds suggesting that coumarins could be an interesting scaffold for developing new therapeutic anti-inflammatory agents. However, despite the continuous efforts of research in this field, no major breakthrough was yet achieved and only a few coumarin-like drugs are commercially available. In the present article, we reviewed the most relevant studies conducted in the last two decades (2000-2021) and presenting evidence for the anti-inflammatory mechanisms of coumarins. The review provides a comprehensive survey of scientific research revealing through multiple in vitro and in vivo models the effect of natural and synthetic coumarins on components of the Toll-like receptors (TLR), Janus Kinase/Signal Transducer and Activator of Transcription (JAK/STAT), Inflammasomes, mitogen-activated protein kinase (MAPK), nuclear factor- κ-light-chain-enhancer of activated B cells (NF- κB) and transforming growth factor-β/small mothers against decapentaplegic (TGF-β/SMAD) pathways.</AbstractText>
          <CopyrightInformation>Copyright © 2022 Elsevier B.V. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Rostom</LastName>
            <ForeName>Batoul</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratoire de Génomique, Bioinformatique et Chimie Moléculaire (EA 7528), Conservatoire National des Arts et Métiers (Cnam), 2 rue Conté, 75003, HESAM Université, Paris, France; Laboratoire de valorisation des ressources naturelles et des produits de santé, Faculté de Pharmacie, Université Libanaise, Campus Universitaire Rafik Hariri, Hadat, Liban.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Karaky</LastName>
            <ForeName>Racha</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratoire de valorisation des ressources naturelles et des produits de santé, Faculté de Pharmacie, Université Libanaise, Campus Universitaire Rafik Hariri, Hadat, Liban. Electronic address: racha.karaky@ul.edu.lb.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kassab</LastName>
            <ForeName>Issam</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratoire de valorisation des ressources naturelles et des produits de santé, Faculté de Pharmacie, Université Libanaise, Campus Universitaire Rafik Hariri, Hadat, Liban.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sylla-Iyarreta Veitía</LastName>
            <ForeName>Maité</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratoire de Génomique, Bioinformatique et Chimie Moléculaire (EA 7528), Conservatoire National des Arts et Métiers (Cnam), 2 rue Conté, 75003, HESAM Université, Paris, France. Electronic address: maite.sylla@lecnam.net.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>03</Month>
          <Day>03</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>Eur J Pharmacol</MedlineTA>
        <NlmUniqueID>1254354</NlmUniqueID>
        <ISSNLinking>0014-2999</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000893">Anti-Inflammatory Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D003374">Coumarins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000893" MajorTopicYN="N">Anti-Inflammatory Agents</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003374" MajorTopicYN="N">Coumarins</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016328" MajorTopicYN="Y">NF-kappa B</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="Y">Signal Transduction</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Coumarins</Keyword>
        <Keyword MajorTopicYN="N">Inflammasomes</Keyword>
        <Keyword MajorTopicYN="N">Inflammatory signaling pathways</Keyword>
        <Keyword MajorTopicYN="N">JAK/STAT pathway</Keyword>
        <Keyword MajorTopicYN="N">MAPK pathway</Keyword>
        <Keyword MajorTopicYN="N">NF-κB pathway</Keyword>
        <Keyword MajorTopicYN="N">TGF-β/SMAD pathway</Keyword>
        <Keyword MajorTopicYN="N">Toll-like receptors</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>6</Day>
          <Hour>20</Hour>
          <Minute>29</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35248553</ArticleId>
        <ArticleId IdType="doi">10.1016/j.ejphar.2022.174867</ArticleId>
        <ArticleId IdType="pii">S0014-2999(22)00128-5</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
